TITLE

More on DSMBs

AUTHOR(S)
Rosenblatt, Michael; Kim, Peter S.
PUB. DATE
May 2011
SOURCE
New England Journal of Medicine;5/12/2011, Vol. 364 Issue 19, p1879
SOURCE TYPE
Academic Journal
DOC. TYPE
Letter
ABSTRACT
A letter to the editor is presented in response to the article "Don't Mess With the DSMB," J. M. Drazen and A. J. J. Wood, in the July 29, 2010 issue.
ACCESSION #
60596276

 

Related Articles

  • Liptruzet.  // MPR - Pharmacist's Edition;Fall2013, Vol. 7 Issue 3, pA5 

    The article offers brief information on the Liptruzet ezetimibe and atorvastatin tablets from Merck & Co. Inc.

  • VIOXX: A SECOND OPINION. Frazier, Kenneth C. // Prospect;Dec2008, Issue 153, p7 

    A letter to the editor is presented in response to the article "How Merck Made a Killing" by Jim Giles in the November 2008 issue of the journal.

  • Take Two Aspirin, Call a Lawyer. Marans, Nelson; Shmavonian, Karl // Forbes Global;11/29/2004, Vol. 7 Issue 21, p6 

    Presents a letter to the editor in response to the article "Merck's Mess," in the November 1, 2004 issue of "Forbes Global" magazine.

  • More evidence is needed on ezetimibe. Lockhat, Mohamed // Pulse;10/19/2011, Vol. 71 Issue 34, p20 

    A letter to the editor is presented in response to the article "Ezetimibe plus statin halves death risk."

  • productshowcase.  // Pharmacy Today;Jun2013, Vol. 19 Issue 6, p20 

    The article offers information on several newly approved drugs by the U.S. Food and Drug Administration (FDA). It states that Liptruzet atorvastin/ezetimibe from Merck has been approved for treating elevated low-density lipoprotein (LDL) cholesterol levels in mixed or primary hyperlipidemia...

  • Patent watch. Harrison, Charlotte // Nature Reviews Drug Discovery;Jun2010, Vol. 9 Issue 6, p424 

    The article offers news briefs related to patents. The U.S. Patent and Trademark Office's (PTO) Board of Patent Appeals has decided that the stem cell patent owned by the Wisconsin Alumni Research Foundation (WARF) is invalid. Glenmark Pharmaceuticals Inc. and Merck & Co. Inc. has reached...

  • Letters to the Editor. Beecham, Margaret A.; Denysyk, Oleh // Pharmaceutical Executive;Oct2006, Vol. 26 Issue 10, p16 

    Two letters to the editor are presented in response to articles in previous issues including article about Merck & Co. Inc. and former GD Searle and "Successful Clinical Trials Management" in the June 2006 issue.

  • Letters.  // Time;9/8/1952, Vol. 60 Issue 10, p10 

    Several letters to the editor are presented in response to articles in previous 1952 issues including the report "Afternoon of a Roebuck" and the cover story about drug company Merck & Co., which appeared in the August 18 issue, and an article about U.S. Senator Richard Nixon, which appeared in...

  • Reply to the letter by M. Yoneda et al. regarding 'Ezetimibe therapy in patients with nonalcoholic steatohepatitis'. Park, Hyohun; Okanoue, Takeshi // Journal of Gastroenterology;Mar2011, Vol. 46 Issue 3, p417 

    No abstract available.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics